Plant flavonoids in cancer chemoprevention: role in genome stability

Journal of Nutritional Biochemistry

Volumn 45, Issue , 2017, Pages 1-14

  George, Vazhappilly Cijo ^a   Dellaire, Graham ^b   Rupasinghe, H P Vasantha ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cancer; Chemoprevention; Dietary antioxidants; DNA damage detection; DNA damage signaling and repair; Flavonoids; Genome stability; Polyphenols

Indexed keywords

ANTHOCYANIN; APIGENIN; CELL DNA; CHRYSIN; DAIDZEIN; EPIGALLOCATECHIN GALLATE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; GENISTEIN; ISOFLAVONE DERIVATIVE; LUTEOLIN; MALVIDIN CHLORIDE; POLYPHENOL; PROANTHOCYANIDIN; QUERCETIN; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL DEATH; CELL PROTECTION; CHEMOPROPHYLAXIS; COST EFFECTIVENESS ANALYSIS; DNA ADDUCT; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA REPAIR; GENOMIC INSTABILITY; HUMAN; MEDICINAL PLANT; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TUNEL ASSAY; CHEMISTRY; DIET; DRUG EFFECTS; GENETICS; NEOPLASM; PLANT;

ANTICARCINOGENIC AGENTS; DIET; DNA DAMAGE; DNA REPAIR; FLAVONOIDS; GENOMIC INSTABILITY; HUMANS; NEOPLASMS; PLANTS; POLYPHENOLS;

EID: 85002951679     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2016.11.007     Document Type: Review

References (180)

1. [1] Seyfried, T.N., Shelton, L.M., Cancer as a metabolic disease. Nutr Metab (Lond), 2010, 7.
2. [2] Trosko, J.E., Kang, K.S., Evolution of energy metabolism, stem cells and cancer stem cells: how the Warburg and Barker hypotheses might be linked. Int J Stem Cells 5 (2012), 39–56.
3. [3] Block, K.I., Gyllenhaal, C., Lowe, L., Amedei, A., Amin, A.R., Amin, A., et al. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol(Suppl. 35), 2015, S276–S304.
4. [4] Wajed, S.A., Laird, P.W., DeMeester, T.R., DNA methylation: an alternative pathway to cancer. Ann Surg 234 (2001), 10–20.
5. [5] Weitzman, M.D., Lilley, C.E., Chaurushiya, M.S., Genomes in conflict: maintaining genome integrity during virus infection. Annu Rev Microbiol 64 (2010), 61–81.
6. [6] B, D.A., H, W.C., P, D.S., Destabilization of the cancer genome. Cancer: principles & practice of oncology, 8 ed., 2008.
7. [7] Rajendran, P., Ho, E., Williams, D.E., Dashwood, R.H., Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenetics, 3, 2011, 4.
8. [8] Cheung-Ong, K., Giaever, G., Nislow, C., DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology. Chem Biol 20 (2013), 648–659.
9. [9] Woods, D., Turchi, J.J., Chemotherapy induced DNA damage response: convergence of drugs and pathways. Cancer Biol Ther 14 (2013), 379–389.
10. [10] Helleday, T., Petermann, E., Lundin, C., Hodgson, B., Sharma, R.A., DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 8 (2008), 193–204.
11. [11] Kelland, L., The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7 (2007), 573–584.
12. [12] Longley, D.B., Harkin, D.P., Johnston, P.G., 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3 (2003), 330–338.
13. [13] Pommier, Y., Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 6 (2006), 789–802.
14. [14] Zhou, B.B.S., Elledge, S.J., The DNA damage response: putting checkpoints in perspective. Nature 408 (2000), 433–439.
15. [15] Ciccia, A., Elledge, S.J., The DNA damage response: making it safe to play with knives. Mol Cell 40 (2010), 179–204.
16. [16] Bartkova, J., Horejsi, Z., Koed, K., Kramer, A., Tort, F., Zieger, K., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005), 864–870.
17. [17] Pandita, T.K., Richardson, C., Chromatin remodeling finds its place in the DNA double-strand break response. Nucleic Acids Res 37 (2009), 1363–1377.
18. [18] Stokes, M.P., Rush, J., MacNeill, J., Ren, J.M., Sprott, K., Nardone, J., et al. Profiling of UV-induced ATM/ATR signaling pathways. Proc Natl Acad Sci U S A 104 (2007), 19855–19860.
19. [19] Jette, N., Lees-Miller, S.P., The DNA-dependent protein kinase: a multifunctional protein kinase with roles in DNA double strand break repair and mitosis. Prog Biophys Mol Biol 117 (2015), 194–205.
20. [20] Matsuoka, S., Ballif, B.A., Smogorzewska, A., McDonald, E.R. III, Hurov, K.E., Luo, J., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316 (2007), 1160–1166.
21. [21] Gong, F.D., Miller, K.M., Mammalian DNA repair: HATs and HDACs make their mark through histone acetylation. Mutat Res-Fund Mol M 750 (2013), 23–30.
22. [22] Barneda-Zahonero, B., Parra, M., Histone deacetylases and cancer. Mol Oncol 6 (2012), 579–589.
23. [23] Kachhap, S.K., Rosmus, N., Collis, S.J., Kortenhorst, M.S.Q., Wissing, M.D., Hedayati, M., et al. Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor. PLoS One, 5, 2010.
24. [24] Bonisch, C., Hake, S.B., Histone H2A variants in nucleosomes and chromatin: more or less stable?. Nucleic Acids Res 40 (2012), 10719–10741.
25. [25] Harper, J.W., Elledge, S.J., The DNA damage response: ten years after. Mol Cell 28 (2007), 739–745.
26. [26] Petrini, J.H., Cell signaling. A touching response to damage. Science 316 (2007), 1138–1139.
27. [27] Zannini, L., Delia, D., Buscemi, G., CHK2 kinase in the DNA damage response and beyond. J Mol Cell Biol 6 (2014), 442–457.
28. [28] Bhattacharyya, A., Ear, U.S., Koller, B.H., Weichselbaum, R.R., Bishop, D.K., The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem 275 (2000), 23899–23903.
29. [29] Dray, E., Etchin, J., Wiese, C., Saro, D., Williams, G.J., Hammel, M., et al. Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2. Nat Struct Mol Biol 17 (2010), 1255–1259.
30. [30] Buisson, R., Dion-Cote, A.M., Coulombe, Y., Launay, H., Cai, H., Stasiak, A.Z., et al. Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination. Nat Struct Mol Biol 17 (2010), 1247–1254.
31. [31] Meek, D.W., The p53 response to DNA damage. DNA Repair (Amst) 3 (2004), 1049–1056.
32. [32] Nevanlinna, H., Bartek, J., The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25 (2006), 5912–5919.
33. [33] Solomon, S., Das, S., Brand, R., Whitcomb, D.C., Inherited pancreatic cancer syndromes. Cancer J 18 (2012), 485–491.
34. [34] McBride, K.A., Ballinger, M.L., Killick, E., Kirk, J., Tattersall, M.H., Eeles, R.A., et al. Li-Fraumeni syndrome: cancer risk assessment and clinical management. Nat Rev Clin Oncol 11 (2014), 260–271.
35. [35] O'Sullivan, C.C., Moon, D.H., Kohn, E.C., Lee, J.M., Beyond breast and ovarian cancers: PARP inhibitors for BRCA mutation-associated and BRCA-like solid tumors. Front Oncol, 4, 2014, 42.
36. [36] Langie, S.A., Koppen, G., Desaulniers, D., Al-Mulla, F., Al-Temaimi, R., Amedei, A., et al. Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis 36:Suppl. 1 (2015), S61–S88.
37. [37] Ayoub, N., Rajendra, E., Su, X., Jeyasekharan, A.D., Mahen, R., Venkitaraman, A.R., The carboxyl terminus of Brca2 links the disassembly of Rad51 complexes to mitotic entry. Curr Biol 19 (2009), 1075–1085.
38. [38] Chen, C.C., Carson, J.J., Feser, J., Tamburini, B., Zabaronick, S., Linger, J., et al. Acetylated lysine 56 on histone H3 drives chromatin assembly after repair and signals for the completion of repair. Cell 134 (2008), 231–243.
39. [39] Bishop, K.S., Ferguson, L.R., The interaction between epigenetics, nutrition and the development of cancer. Nutrients 7 (2015), 922–947.
40. [40] Shukla, S., Meeran, S.M., Katiyar, S.K., Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention. Cancer Lett 355 (2014), 9–17.
41. [41] Berman, B.P., Weisenberger, D.J., Aman, J.F., Hinoue, T., Ramjan, Z., Liu, Y., et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet 44 (2012), 40–46.
42. [42] Lahtz, C., Pfeifer, G.P., Epigenetic changes of DNA repair genes in cancer. J Mol Cell Biol 3 (2011), 51–58.
43. [43] Jiricny, J., The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 7 (2006), 335–346.
44. [44] Hoeijmakers, J.H.J., DNA damage, aging, and cancer. (vol 361, p 1475, 2009). N Engl J Med, 361, 2009, 1914.
45. [45] Bennardo, N., Cheng, A., Huang, N., Stark, J.M., Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet, 4, 2008.
46. [46] Svetlova, M.R., Solovjeva, L.V., Tomilin, N.V., Application of new methods for detection of DNA damage and repair. Int Rev Cel Mol Biol 277 (2009), 217–251.
47. [47] Collins, A.R., Dusinska, M., Horvathova, E., Munro, E., Savio, M., Stetina, R., Inter-individual differences in repair of DNA base oxidation, measured in vitro with the comet assay. Mutagenesis 16 (2001), 297–301.
48. [48] Collins, A.R., Investigating oxidative DNA damage and its repair using the comet assay. Mutat Res 681 (2009), 24–32.
49. [49] Charles, C., Chemais, M., Stevigny, C., Dubois, J., Nachergael, A., Duez, P., Measurement of the influence of flavonoids on DNA repair kinetics using the comet assay. Food Chem 135 (2012), 2974–2981.
50. [50] Schmid, T.E., Zlobinskaya, O., Multhoff, G., Differences in phosphorylated histone H2AX foci formation and removal of cells exposed to low and high linear energy transfer radiation. Curr Genomics 13 (2012), 418–425.
51. [51] Mailand, N., Bekker-Jensen, S., Faustrup, H., Melander, F., Bartek, J., Lukas, C., et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131 (2007), 887–900.
52. [52] Hilchie, A.L., Doucette, C.D., Pinto, D.M., Patrzykat, A., Douglas, S., Hoskin, D.W., Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts. Breast Cancer Res, 13, 2011.
53. [53] Chaurio, R.A., Munoz, L.E., Maueroder, C., Janko, C., Harrer, T., Furnrohr, B.G., et al. The progression of cell death affects the rejection of allogeneic tumors in immune-competent mice - implications for cancer therapy. Front Immunol, 5, 2014, 560.
54. [54] Gescher, A., Pastorino, U., Plummer, S.M., Manson, M.M., Suppression of tumour development by substances derived from the diet-mechanisms and clinical implications. Br J Clin Pharmacol 45 (1998), 1–12.
55. [55] De Angelis, C., Side effects related to systemic cancer treatment: are we changing the promethean experience with molecularly targeted therapies?. Curr Oncol 15 (2008), 198–199.
56. [56] Chou, T.C., Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70 (2010), 440–446.
57. [57] Chabner, B.A., Roberts, T.G. Jr., Timeline: chemotherapy and the war on cancer. Nat Rev Cancer 5 (2005), 65–72.
58. [58] Monasterio, A., Urdaci, M.C., Pinchuk, I.V., Lopez-Moratalla, N., Martinez-Irujo, J.J., Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways. Nutr Cancer 50 (2004), 90–100.
59. [59] Brusselmans, K., Vrolix, R., Verhoeven, G., Swinnen, J.V., Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J Biol Chem 280 (2005), 5636–5645.
60. [60] Hussain, M.S., Fareed, S., Ansari, S., Rahman, M.A., Ahmad, I.Z., Saeed, M., Current approaches toward production of secondary plant metabolites. J Pharm Bioallied Sci 4 (2012), 10–20.
61. [61] Fernando, F., Rupasinghe, H.P.V., Anticancer properties of phytochemicals present in medicinal plants of North America. Using old solutions to new problems — natural drug discovery in the 21st century, 2013, InTech - Open Access Publisher, Croatia.
62. [62] Ziaullah, Rupasinghe, H.P.V., Application of NMR spectroscopy in plant phenolics associated with human health. Application of NMR spectroscopy in food sciences, 2015, Bentham Science, Oak Park, IL, USA.
63. [63] Jones, Q.R., Warford, J., Rupasinghe, H.P.V., Robertson, G.S., Target-based selection of flavonoids for neurodegenerative disorders. Trends Pharmacol Sci 33 (2012), 602–610.
64. [64] Thilakarathna, S.H., Rupasinghe, H.P.V., Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 5 (2013), 3367–3387.
65. [65] Chow, H.H., Hakim, I.A., Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res 64 (2011), 105–112.
66. [66] Marin, L., Miguelez, E.M., Villar, C.J., Lombo, F., Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. Biomed Res Int, 2015, 2015, 905215.
67. [67] Landete, J.M., Updated knowledge about polyphenols: functions, bioavailability, metabolism, and health. Crit Rev Food Sci Nutr 52 (2012), 936–948.
68. [68] Kim, D.H., Gut microbiota-mediated drug-antibiotic interactions. Drug Metab Dispos 43 (2015), 1581–1589.
69. [69] Graefe, E.U., Wittig, J., Mueller, S., Riethling, A.K., Uehleke, B., Drewelow, B., et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41 (2001), 492–499.
70. [70] Manach, C., Williamson, G., Morand, C., Scalbert, A., Remesy, C., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81 (2005), 230S–242S.
71. [71] Matsuo, M., Sasaki, N., Saga, K., Kaneko, T., Cytotoxicity of flavonoids toward cultured normal human cells. Biol Pharm Bull 28 (2005), 253–259.
72. [72] Shanmugam, M.K., Kannaiyan, R., Sethi, G., Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer 63 (2011), 161–173.
73. [73] Rupasinghe, H.P.V., Nair, S., Robinson, R., Chemopreventive properties of fruit phenolics and their possible mode of actions. In: Studies in natural products chemistry. 2014, Elsevier Science Publishers, Amsterdam.
74. [74] Arumuggam, N., Bhowmick, N.A., Rupasinghe, H.P.V., A review: phytochemicals targeting JAK/STAT signaling and IDO expression in cancer. Phytother Res 29 (2015), 805–817.
75. [75] Meyer, H., Bolarinwa, A., Wolfram, G., Linseisen, J., Bioavailability of apigenin from apiin-rich parsley in humans. Ann Nutr Metab 50 (2006), 167–172.
76. [76] Das, S., Das, J., Paul, A., Samadder, A., Khuda-Bukhsh, A.R., Apigenin, a bioactive flavonoid from Lycopodium clavatum, stimulates nucleotide excision repair genes to protect skin keratinocytes from ultraviolet B-induced reactive oxygen species and DNA damage. J Acupunct Meridian Stud 6 (2013), 252–262.
77. [77] Mazza, G., Anthocyanins in grapes and grape products. Crit Rev Food Sci Nutr 35 (1995), 341–371.
78. [78] Birt, D.F., Mitchell, D., Gold, B., Pour, P., Pinch, H.C., Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 17 (1997), 85–91.
79. [79] Shi, M.D., Shiao, C.K., Lee, Y.C., Shih, Y.W., Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis. Cancer Cell Int, 15, 2015, 33.
80. [80] Gates, M.A., Vitonis, A.F., Tworoger, S.S., Rosner, B., Titus-Ernstoff, L., Hankinson, S.E., et al. Flavonoid intake and ovarian cancer risk in a population-based case–control study. Int J Cancer 124 (2009), 1918–1925.
81. [81] Duarte, S., Arango, D., Parihar, A., Hamel, P., Yasmeen, R., Doseff, A.I., Apigenin protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function. Int J Mol Sci 14 (2013), 17664–17679.
82. [82] Arango, D., Parihar, A., Villamena, F.A., Wang, L., Freitas, M.A., Grotewold, E., et al. Apigenin induces DNA damage through the PKCdelta-dependent activation of ATM and H2AX causing down-regulation of genes involved in cell cycle control and DNA repair. Biochem Pharmacol 84 (2012), 1571–1580.
83. [83] Kroonen, J., Artesi, M., Capraro, V., Nguyen-Khac, M.T., Willems, M., Chakravarti, A., et al. Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells. Int J Oncol 41 (2012), 776–782.
84. [84] Yin, S.T., Tang, M.L., Su, L., Chen, L., Hu, P., Wang, H.L., et al. Effects of epigallocatechin-3-gallate on lead-induced oxidative damage. Toxicology 249 (2008), 45–54.
85. [85] Zhu, W., Xu, J., Ge, Y.Y., Cao, H., Ge, X., Luo, J.D., et al. Epigallocatechin-3-gallate (EGCG) protects skin cells from ionizing radiation via heme oxygenase-1 (HO-1) overexpression. J Radiat Res (Tokyo) 55 (2014), 1056–1065.
86. [86] Morley, N., Clifford, T., Salter, L., Campbell, S., Gould, D., Curnow, A., The green tea polyphenol (−)-epigallocatechin gallate and green tea can protect human cellular DNA from ultraviolet and visible radiation-induced damage. Photodermatol Photoimmunol Photomed 21 (2005), 15–22.
87. [87] Richi, B., Kale, R.K., Tiku, A.B., Radio-modulatory effects of green tea catechin EGCG on pBR322 plasmid DNA and murine splenocytes against gamma-radiation induced damage. Mutat Res 747 (2012), 62–70.
88. [88] Silva, J.P., Gomes, A.C., Coutinho, O.P., Oxidative DNA damage protection and repair by polyphenolic compounds in PC12 cells. Eur J Pharmacol 601 (2008), 50–60.
89. [89] Leung, H.W., Wu, C.H., Lin, C.H., Lee, H.Z., Luteolin induced DNA damage leading to human lung squamous carcinoma CH27 cell apoptosis. Eur J Pharmacol 508 (2005), 77–83.
90. [90] Shi, R., Huang, Q., Zhu, X., Ong, Y.B., Zhao, B., Lu, J., et al. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Mol Cancer Ther 6 (2007), 1338–1347.
91. [91] George, V.C., Naveen Kumar, D.R., Suresh, P.K., Kumar, S., Kumar, R.A., Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells. Asian Pac J Cancer Prev 14 (2013), 631–637.
92. [92] Byun, S., Lee, K.W., Jung, S.K., Lee, E.J., Hwang, M.K., Lim, S.H., et al. Luteolin inhibits protein kinase C(epsilon) and c-Src activities and UVB-induced skin cancer. Cancer Res 70 (2010), 2415–2423.
93. [93] Seelinger, G., Merfort, I., Wolfle, U., Schempp, C.M., Anti-carcinogenic effects of the flavonoid luteolin. Molecules 13 (2008), 2628–2651.
94. [94] Rao, P.S., Satelli, A., Moridani, M., Jenkins, M., Rao, U.S., Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: involvement of cell line-specific apoptotic mechanisms. Int J Cancer 130 (2012), 2703–2714.
95. [95] Sudan, S., Rupasinghe, H.P.V., Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells. Anticancer Res 34 (2014), 1691–1699.
96. [96] Yamashita, N., Tanemura, H., Kawanishi, S., Mechanism of oxidative DNA damage induced by quercetin in the presence of Cu(II). Mutat Res 425 (1999), 107–115.
97. [97] Min, K., Ebeler, S.E., Quercetin inhibits hydrogen peroxide-induced DNA damage and enhances DNA repair in Caco-2 cells. Food Chem Toxicol 47 (2009), 2716–2722.
98. [98] Ozyurt, H., Cevik, O., Ozgen, Z., Ozden, A.S., Cadirci, S., Elmas, M.A., et al. Quercetin protects radiation-induced DNA damage and apoptosis in kidney and bladder tissues of rats. Free Radic Res 48 (2014), 1247–1255.
99. [99] Yamazaki, S., Sakakibara, H., Takemura, H., Yasuda, M., Shimoi, K., Quercetin-3-O-glucronide inhibits noradrenaline binding to alpha(2)-adrenergic receptor, thus suppressing DNA damage induced by treatment with 4-hydroxyestradiol and noradrenaline in MCF-10A cells. J Steroid Biochem Mol Biol 143 (2014), 122–129.
100. [100] Sun, B., Ross, S.M., Trask, O.J., Carmichael, P.L., Dent, M., White, A., et al. Assessing dose-dependent differences in DNA-damage, p53 response and genotoxicity for quercetin and curcumin. Toxicol In Vitro 27 (2013), 1877–1887.
101. [101] Manzolli, E.S., Serpeloni, J.M., Grotto, D., Bastos, J.K., Antunes, L.M., Barbosa Junior, F., et al. Protective effects of the flavonoid chrysin against methylmercury-induced genotoxicity and alterations of antioxidant status, in vivo. Oxid Med Cell Longev, 2015, 2015, 602360.
102. [102] Anand, K.V., Mohamed Jaabir, M.S., Thomas, P.A., Geraldine, P., Protective role of chrysin against oxidative stress in D-galactose-induced aging in an experimental rat model. Geriatr Gerontol Int 12 (2012), 741–750.
103. [103] T M, R V, Effects of chrysin on free radicals and enzymatic antioxidants in Nω-nitro-l-arginine methyl ester: induced hypertensive rats. Int J Nutr Pharmacol Neurol Dis 4 (2014), 112–117.
104. [104] Iovine, B., Iannella, M.L., Gasparri, F., Monfrecola, G., Bevilacqua, M.A., Synergic effect of genistein and daidzein on UVB-induced DNA damage: an effective photoprotective combination. J Biomed Biotechnol, 2011, 2011, 692846.
105. [105] Paixao, J., Dinis, T.C., Almeida, L.M., Protective role of malvidin-3-glucoside on peroxynitrite-induced damage in endothelial cells by counteracting reactive species formation and apoptotic mitochondrial pathway. Oxid Med Cell Longev, 2012, 2012, 428538.
106. [106] Khandelwal, N., Abraham, S.K., Protective effects of common anthocyanidins against genotoxic damage induced by chemotherapeutic drugs in mice. Planta Med 80 (2014), 1278–1283.
107. [107] Kara, S., Gencer, B., Karaca, T., Tufan, H.A., Arikan, S., Ersan, I., et al. Protective effect of hesperetin and naringenin against apoptosis in ischemia/reperfusion-induced retinal injury in rats. ScientificWorldJournal, 2014, 2014, 797824.
108. [108] Trivedi, P.P., Kushwaha, S., Tripathi, D.N., Jena, G.B., Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat. Cardiovasc Toxicol 11 (2011), 215–225.
109. [109] Lapenna, S., Giordano, A., Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov 8 (2009), 547–566.
110. [110] El-Mahdy, M.A., Zhu, Q., Wang, Q.E., Wani, G., Patnaik, S., Zhao, Q., et al. Naringenin protects HaCaT human keratinocytes against UVB-induced apoptosis and enhances the removal of cyclobutane pyrimidine dimers from the genome. Photochem Photobiol 84 (2008), 307–316.
111. [111] Boligon, A.A., Sagrillo, M.R., Machado, L.F., de Souza, F.O., Machado, M.M., da Cruz, I.B., et al. Protective effects of extracts and flavonoids isolated from Scutia buxifolia Reissek against chromosome damage in human lymphocytes exposed to hydrogen peroxide. Molecules 17 (2012), 5757–5769.
112. [112] Quan, Y., Yang, Y., Wang, H., Shu, B., Gong, Q.H., Qian, M., Gypenosides attenuate cholesterol-induced DNA damage by inhibiting the production of reactive oxygen species in human umbilical vein endothelial cells. Mol Med Rep 11 (2015), 2845–2851.
113. [113] Srivastava, N.N., Shukla, S.K., Yashavarddhan, M.H., Devi, M., Tripathi, R.P., Gupta, M.L., Modification of radiation-induced DNA double strand break repair pathways by chemicals extracted from Podophyllum hexandrum: an in vitro study in human blood leukocytes. Environ Mol Mutagen 55 (2014), 436–448.
114. [114] Shah, N., Singh, R., Sarangi, U., Saxena, N., Chaudhary, A., Kaur, G., et al. Combinations of Ashwagandha leaf extracts protect brain-derived cells against oxidative stress and induce differentiation. PLoS One, 10, 2015.
115. [115] Rastogi, L., Feroz, S., Pandey, B.N., Jagtap, A., Mishra, K.P., Protection against radiation-induced oxidative damage by an ethanolic extract of Nigella sativa L. Int J Radiat Biol 86 (2010), 719–731.
116. [116] Cheng, N., Wang, Y., Gao, H., Yuan, J., Feng, F., Cao, W., et al. Protective effect of extract of Crataegus pinnatifida pollen on DNA damage response to oxidative stress. Food Chem Toxicol 59 (2013), 709–714.
117. [117] Yeh, C.C., Yang, J.I., Lee, J.C., Tseng, C.N., Chan, Y.C., Hseu, Y.C., et al. Anti-proliferative effect of methanolic extract of Gracilaria tenuistipitata on oral cancer cells involves apoptosis, DNA damage, and oxidative stress. BMC Complement Altern Med, 12, 2012.
118. [118] Lam, M., Carmichael, A.R., Griffiths, H.R., An aqueous extract of Fagonia cretica induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells via FOXO3a and p53 expression. PLoS One, 7, 2012, e40152.
119. [119] Hsieh, T., Lin, C., Lin, H., Wu, J., AKT/mTOR as novel targets of polyphenol piceatannol possibly contributing to inhibition of proliferation of cultured prostate cancer cells. ISRN Urol, 8, 2012.
120. [120] Speich, H.E., Grgurevich, S., Kueter, T.J., Earhart, A.D., Slack, S.M., Jennings, L.K., Platelets undergo phosphorylation of Syk at Y525/526 and Y352 in response to pathophysiological shear stress. Am J Physiol 295 (2008), C1045–C1054.
121. [121] Lee, Y.M., Lim, D.Y., Cho, H.J., Seon, M.R., Kim, J.K., Lee, B.Y., et al. Piceatannol, a natural stilbene from grapes, induces G1 cell cycle arrest in androgen-insensitive DU145 human prostate cancer cells via the inhibition of CDK activity. Cancer Lett 285 (2009), 166–173.
122. [122] Shiratake, S., Nakahara, T., Iwahashi, H., Onodera, T., Mizushina, Y., Rose myrtle (Rhodomyrtus tomentosa) extract and its component, piceatannol, enhance the activity of DNA polymerase and suppress the inflammatory response elicited by UVB-induced DNA damage in skin cells. Mol Med Rep 12 (2015), 5857–5864.
123. [123] Syed, D.N., Afaq, F., Maddodi, N., Johnson, J.J., Sarfaraz, S., Ahmad, A., et al. Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/beta-catenin signaling and decreased Mitf levels. J Invest Dermatol 131 (2011), 1291–1299.
124. [124] Huang, S.L., Inhibition of PI3K/Akt/mTOR signaling by natural products. Anticancer Agents Med Chem 13 (2013), 967–970.
125. [125] Sun, H., Wang, Z.Y., Yakisich, J.S., Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents. Anticancer Agents Med Chem 13 (2013), 1048–1056.
126. [126] George, V.C., Kumar, D.R., Suresh, P.K., Kumar, R.A., Antioxidant, DNA protective efficacy and HPLC analysis of Annona muricata (soursop) extracts. J Food Sci Technol 52 (2015), 2328–2335.
127. [127] Muanda, F., Kone, D., Dicko, A., Soulimani, R., Younos, C., Phytochemical composition and antioxidant capacity of three Malian medicinal plant parts. Evid Based Complement Alternat Med, 2011, 2011, 674320.
128. [128] Ahmed, M.A., El Morsy, E.M., Ahmed, A.A., Pomegranate extract protects against cerebral ischemia/reperfusion injury and preserves brain DNA integrity in rats. Life Sci 110 (2014), 61–69.
129. [129] Guo, C.J., Wei, J.Y., Yang, J.J., Xu, J., Pang, W., Jiang, Y.G., Pomegranate juice is potentially better than apple juice in improving antioxidant function in elderly subjects. Nutr Res 28 (2008), 72–77.
130. [130] Liu, H.S., Pan, C.E., Yang, W., Liu, X.M., Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J Gastroenterol 9 (2003), 1474–1476.
131. [131] Pasciu, V., Posadino, A.M., Cossu, A., Sanna, B., Tadolini, B., Gaspa, L., et al. Akt downregulation by flavin oxidase-induced ROS generation mediates dose-dependent endothelial cell damage elicited by natural antioxidants. Toxicol Sci 114 (2010), 101–112.
132. [132] Singh, N.P., Singh, U.S., Nagarkatti, M., Nagarkatti, P.S., Resveratrol (3,5,4′-trihydroxystilbene) protects pregnant mother and fetus from the immunotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Nutr Food Res 55 (2011), 209–219.
133. [133] Zafra-Stone, S., Yasmin, T., Bagchi, M., Chatterjee, A., Vinson, J.A., Bagchi, D., Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol Nutr Food Res 51 (2007), 675–683.
134. [134] Giampieri, F., Alvarez-Suarez, J.M., Mazzoni, L., Forbes-Hernandez, T.Y., Gasparrini, M., Gonzalez-Paramas, A.M., et al. Polyphenol-rich strawberry extract protects human dermal fibroblasts against hydrogen peroxide oxidative damage and improves mitochondrial functionality. Molecules 19 (2014), 7798–7816.
135. [135] Ochmian, I., Grajkowski, J., Skupien, K., Yield and chemical composition of blue honeysuckle fruit depending on ripening time. Bull UASVM Hort 67 (2010), 138–147.
136. [136] Rupasinghe, H.P.V., Boehm, M.M.A., Sekhon-Loodu, S., Parmar, I., Bors, B., Jamieson, A.R., Anti-inflammatory activity of haskap cultivars is polyphenols-dependent. Biomolecules 5 (2015), 1079–1098.
137. [137] Rupasinghe, H.P.V., Yu, L.J., Bhullar, K.S., Bors, B., Haskap (Lonicera caerulea): a new berry crop with high antioxidant capacity. Can J Plant Sci 92 (2012), 1311–1317.
138. [138] Zhao, H.T., Wang, Z.Y., Ma, F.M., Yang, X., Cheng, C.L., Yao, L., Protective effect of anthocyanin from Lonicera caerulea var. edulis on radiation-induced damage in mice. Int J Mol Sci 13 (2012), 11773–11782.
139. [139] Rajnochova Svobodova, A., Galandakova, A., Palikova, I., Dolezal, D., Kylarova, D., Ulrichova, J., et al. Effects of oral administration of Lonicera caerulea berries on UVB-induced damage in SKH-1 mice. A pilot study. Photochem Photobiol Sci 12 (2013), 1830–1840.
140. [140] Bonarska-Kujawa, D., Pruchnik, H., Cyboran, S., Zylka, R., Oszmianski, J., Kleszczynska, H., Biophysical mechanism of the protective effect of blue honeysuckle (Lonicera caerulea L. Var. Kamtschatica Sevast.) polyphenols extracts against lipid peroxidation of erythrocyte and lipid membranes. J Membr Biol 247 (2014), 611–625.
141. [141] Collins, A.R., Kiwifruit as a modulator of DNA damage and DNA repair. Adv Food Nutr Res 68 (2013), 283–299.
142. [142] Kang, M.H., Park, Y.K., Kim, H.Y., Kim, T.S., Green vegetable drink consumption protects peripheral lymphocytes DNA damage in Korean smokers. Biofactors 22 (2004), 245–247.
143. [143] Pi-Yu, C., Huang, W.-Y., Hu, S.-P., Lo, H.-F., Lin, K.-H., Huang, M.-Y., et al. Indigenous purple vegetable extracts protect against hydrogen peroxide-induced DNA damage in human lymphocytes. Food Nutr Sci 4 (2013), 62–70.
144. [144] Calabrese, E.J., Converging concepts: adaptive response, preconditioning, and the Yerkes-Dodson law are manifestations of hormesis. Ageing Res Rev 7 (2008), 8–20.
145. [145] Calabrese, E.J., Mattson, M.P., Calabrese, V., Resveratrol commonly displays hormesis: occurrence and biomedical significance. Hum Exp Toxicol 29 (2010), 980–1015.
146. [146] Mukherjee, S., Dudley, J.I., Das, D.K., Dose-dependency of resveratrol in providing health benefits. Dose Response 8 (2010), 478–500.
147. [147] Wang, C., Kurzer, M.S., Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 28 (1997), 236–247.
148. [148] Vargas, A.J., Burd, R., Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management. Nutr Rev 68 (2010), 418–428.
149. [149] Kalyuzhny, A.E., Combination of TUNEL assay with immunohistochemistry for simultaneous detection of DNA fragmentation and oxidative cell damage. Methods Mol Biol 682 (2011), 15–27.
150. [150] Muslimovic, A., Ismail, I.H., Gao, Y., Hammarsten, O., An optimized method for measurement of gamma-H2AX in blood mononuclear and cultured cells. Nat Protoc 3 (2008), 1187–1193.
151. [151] Zhao, H., Tanaka, T., Mitlitski, V., Heeter, J., Balazs, E.A., Darzynkiewicz, Z., Protective effect of hyaluronate on oxidative DNA damage in WI-38 and A549 cells. Int J Oncol 32 (2008), 1159–1167.
152. [152] Chen, C., Zhang, L., Huang, N.J., Huang, B., Kornbluth, S., Suppression of DNA-damage checkpoint signaling by Rsk-mediated phosphorylation of Mre11. Proc Natl Acad Sci U S A 110 (2013), 20605–20610.
153. [153] Bombarde, O., Boby, C., Gomez, D., Frit, P., Giraud-Panis, M.J., Gilson, E., et al. TRF2/RAP1 and DNA-PK mediate a double protection against joining at telomeric ends. EMBO J 29 (2010), 1573–1584.
154. [154] Liu, S., Opiyo, S.O., Manthey, K., Glanzer, J.G., Ashley, A.K., Amerin, C., et al. Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress. Nucleic Acids Res 40 (2012), 10780–10794.
155. [155] Weston, A., Bowman, E.D., Shields, P.G., Trivers, G.E., Poirier, M.C., Santella, R.M., et al. Detection of polycyclic aromatic hydrocarbon-DNA adducts in human lung. Environ Health Perspect 99 (1993), 257–259.
156. [156] Du, H.F., Xu, L.H., Wang, H.F., Liu, Y.F., Tang, X.Y., Liu, K.X., et al. Formation of MTBE-DNA adducts in mice measured with accelerator mass spectrometry. Environ Toxicol 20 (2005), 397–401.
157. [157] Snyderwine, E.G., Yamashita, K., Adamson, R.H., Sato, S., Nagao, M., Sugimura, T., et al. Use of the P-32-postlabeling method to detect DNA adducts of 2-amino-3-methylimidazolo[4,5-F]quinoline (Iq) in monkeys fed Iq — identification of the N-(deoxyguanosin-8-Yl)-Iq adduct. Carcinogenesis 9 (1988), 1739–1743.
158. [158] Gunter, M.J., Divi, R.L., Kulldorff, M., Vermeulen, R., Haverkos, K.J., Kuo, M.M., et al. Leukocyte polycyclic aromatic hydrocarbon-DNA adduct formation and colorectal adenoma. Carcinogenesis 28 (2007), 1426–1429.
159. [159] Tilby, M.J., Measuring DNA adducts by immunoassay (ELISA). Methods Mol Med 28 (1999), 121–128.
160. [160] Pratt, M.M., John, K., MacLean, A.B., Afework, S., Phillips, D.H., Poirier, M.C., Polycyclic aromatic hydrocarbon (PAH) exposure and DNA adduct semi-quantitation in archived human tissues. Int J Environ Res Public Health 8 (2011), 2675–2691.
161. [161] Arlt, V.M., Poirier, M.C., Sykes, S.E., John, K., Moserova, M., Stiborova, M., et al. Exposure to benzo[a]pyrene of hepatic cytochrome P450 reductase null (HRN) and P450 reductase conditional null (RCN) mice: detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling. Toxicol Lett 213 (2012), 160–166.
162. [162] Culp, S.J., Roberts, D.W., Talaska, G., Lang, N.P., Fu, P.P., Lay, J.O. Jr., et al. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation. Mutat Res 378 (1997), 97–112.
163. [163] Weston, A., Bowman, E.D., Fluorescence detection of benzo[a]pyrene—DNA adducts in human lung. Carcinogenesis 12 (1991), 1445–1449.
164. [164] Min, W., Ahmad, I., Chang, M.E., Burns, E.M., Qian, Q., Yusuf, N., Baicalin protects keratinocytes from toll-like receptor-4 mediated DNA damage and inflammation following ultraviolet irradiation. Photochem Photobiol 91 (2015), 1435–1443.
165. [165] Min, W., Lin, X.F., Miao, X., Wang, B.T., Yang, Z.L., Luo, D., Inhibitory effects of baicalin on ultraviolet B-induced photo-damage in keratinocyte cell line. Am J Chin Med 36 (2008), 745–760.
166. [166] Piao, M.J., Kim, K.C., Chae, S., Keum, Y.S., Kim, H.S., Hyun, J.W., Protective effect of fisetin (3,7,3′,4′-Tetrahydroxyflavone) against gamma-irradiation-induced oxidative stress and cell damage. Biomol Ther (Seoul) 21 (2013), 210–215.
167. [167] Kang, K.A., Piao, M.J., Kim, K.C., Cha, J.W., Zheng, J., Yao, C.W., et al. Fisetin attenuates hydrogen peroxide-induced cell damage by scavenging reactive oxygen species and activating protective functions of cellular glutathione system. In Vitro Cell Dev Biol Anim 50 (2014), 66–74.
168. [168] Sharma, H., Kanwal, R., Bhaskaran, N., Gupta, S., Plant flavone apigenin binds to nucleic acid bases and reduces oxidative DNA damage in prostate epithelial cells. PLoS One, 9, 2014, e91588.
169. [169] Wilms, L.C., Hollman, P.C., Boots, A.W., Kleinjans, J.C., Protection by quercetin and quercetin-rich fruit juice against induction of oxidative DNA damage and formation of BPDE-DNA adducts in human lymphocytes. Mutat Res 582 (2005), 155–162.
170. [170] Ramos, A.A., Pereira-Wilson, C., Collins, A.R., Protective effects of ursolic acid and luteolin against oxidative DNA damage include enhancement of DNA repair in Caco-2 cells. Mutat Res 692 (2010), 6–11.
171. [171] Bestwick, C.S., Milne, L., Pirie, L., Duthie, S.J., The effect of short-term kaempferol exposure on reactive oxygen levels and integrity of human (HL-60) leukaemic cells. Biochim Biophys Acta 2005 (1740), 340–349.
172. [172] Satyamitra, M., Mantena, S., Nair, C., Chandna, S., The antioxidant flavonoids, orientin and vicenin enhance repair of radiation-induced damage. SAJ Pharm Pharmacol 1 (2014), 1–9.
173. [173] Bing-Rong, Z., Song-Liang, J., Xiao, E.C., Xiang-Fei, L., Bao-Xiang, C., Jie, G., et al. Protective effect of the baicalin against DNA damage induced by ultraviolet B irradiation to mouse epidermis. Photodermatol Photoimmunol Photomed 24 (2008), 175–182.
174. [174] Zhang, J.A., Yin, Z., Ma, L.W., Yin, Z.Q., Hu, Y.Y., Xu, Y., et al. The protective effect of baicalin against UVB irradiation induced photoaging: an in vitro and in vivo study. PLoS One, 9, 2014, e99703.
175. [175] Qi, L., Liu, C.Y., Wu, W.Q., Gu, Z.L., Guo, C.Y., Protective effect of flavonoids from Astragalus complanatus on radiation induced damages in mice. Fitoterapia 82 (2011), 383–392.
176. [176] Marcolin, E., Forgiarini, L.F., Rodrigues, G., Tieppo, J., Borghetti, G.S., Bassani, V.L., et al. Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis. Basic Clin Pharmacol Toxicol 112 (2013), 385–391.
177. [177] Golla, U., Bhimathati, S.S., Evaluation of antioxidant and DNA damage protection activity of the hydroalcoholic extract of Desmostachya bipinnata L. Sci World J, 2014, 2014, 215084.
178. [178] Shukla, S.K., Chaudhary, P., Kumar, I.P., Samanta, N., Afrin, F., Gupta, M.L., et al. Protection from radiation-induced mitochondrial and genomic DNA damage by an extract of Hippophae rhamnoides. Environ Mol Mutagen 47 (2006), 647–656.
179. [179] Gafrikova, M., Galova, E., Sevcovicova, A., Imreova, P., Mucaji, P., Miadokova, E., Extract from Armoracia rusticana and its flavonoid components protect human lymphocytes against oxidative damage induced by hydrogen peroxide. Molecules 19 (2014), 3160–3172.
180. [180] Bhullar, K.S., Rupasinghe, H.P.V., Antioxidant and cytoprotective properties of partridgeberry polyphenols. Food Chem 168 (2015), 595–605.